G307-2969 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(2,3-dihydro-1H-indole-1-sulfonyl)-1H-imidazol-1-yl]acetamide

G307-2969 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(2,3-dihydro-1H-indole-1-sulfonyl)-1H-imidazol-1-yl]acetamide
G307-2969 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(2,3-dihydro-1H-indole-1-sulfonyl)-1H-imidazol-1-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G307-2969
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(2,3-dihydro-1H-indole-1-sulfonyl)-1H-imidazol-1-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G307-2969

Molecular Formula

C21H20N4O5S (C21 H20 N4 O5 S)

Compound Name

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(2,3-dihydro-1H-indole-1-sulfonyl)-1H-imidazol-1-yl]acetamide

IUPAC name

N-(23-dihydro-14-benzodioxin-6-yl)-2-[4-(23-dihydro-1H-indole-1-sulfonyl)-1H-imidazol-1-yl]acetamide

SMILES

O=C(Cn1cnc(S(N(CC2)c3c2cccc3)(=O)=O)c1)Nc(cc1)cc2c1OCCO2

InChI

InChI=1S/C21H20N4O5S/c26-20(23-16-5-6-18-19(11-16)30-10-9-29-18)12-24-13-21(22-14-24)31(27,28)25-8-7-15-3-1-2-4-17(15)25/h1-6,11,13-14H,7-10,12H2,(H,23,26)

InChI Key

LMBRYWXGBQXMBY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14996835

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

440.48

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.457

Distribution Coefficient, logD

1.457

Water Solubility, LogSw

-2.53

Polar Surface Area

82.567

Acid Dissociation Constant (pKa)

11.17

Base Dissociation Constant (pKb)

2.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.80

G307-2969 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G307-2969 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G307-2969?
Check Price and Availability of G307-2969, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G307-2969 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G307-2969
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G307-2969
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G307-2969 available by request